Amina A. Ford

1.1k total citations
6 papers, 515 citations indexed

About

Amina A. Ford is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Amina A. Ford has authored 6 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 3 papers in Immunology. Recurrent topics in Amina A. Ford's work include Asthma and respiratory diseases (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and IL-33, ST2, and ILC Pathways (1 paper). Amina A. Ford is often cited by papers focused on Asthma and respiratory diseases (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and IL-33, ST2, and ILC Pathways (1 paper). Amina A. Ford collaborates with scholars based in United States. Amina A. Ford's co-authors include Mehmet Kesımer, Giorgia Radicioni, Neil E. Alexis, Boris Reidel, Ilona Jaspers, Meghan E. Rebuli, Sabri H. Abdelwahab, Phillip W. Clapp, Jerome Carpenter and Rui Cao and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Science Translational Medicine and The Lancet Respiratory Medicine.

In The Last Decade

Amina A. Ford

6 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amina A. Ford United States 5 234 227 117 71 58 6 515
Elisa McEachern United States 6 184 0.8× 76 0.3× 72 0.6× 65 0.9× 50 0.9× 6 363
Marianne A. van de Pol Netherlands 11 254 1.1× 163 0.7× 107 0.9× 20 0.3× 81 1.4× 18 452
Rachel G. Robison United States 11 194 0.8× 90 0.4× 74 0.6× 20 0.3× 33 0.6× 25 448
M. Asghar Pasha United States 9 160 0.7× 114 0.5× 34 0.3× 56 0.8× 65 1.1× 29 355
Matthew Lyes United States 6 152 0.6× 53 0.2× 56 0.5× 61 0.9× 16 0.3× 8 306
Joon-Woo Bahn South Korea 9 197 0.8× 112 0.5× 38 0.3× 35 0.5× 22 0.4× 15 343
Soichiro Hozawa Japan 14 420 1.8× 354 1.6× 49 0.4× 16 0.2× 63 1.1× 56 596
Raj Kumar India 11 228 1.0× 188 0.8× 30 0.3× 14 0.2× 39 0.7× 49 428
L. Breckler Australia 10 156 0.7× 57 0.3× 69 0.6× 16 0.2× 103 1.8× 11 395
Sherwin A. Gillman United States 14 211 0.9× 145 0.6× 39 0.3× 112 1.6× 20 0.3× 22 610

Countries citing papers authored by Amina A. Ford

Since Specialization
Citations

This map shows the geographic impact of Amina A. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amina A. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amina A. Ford more than expected).

Fields of papers citing papers by Amina A. Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amina A. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amina A. Ford. The network helps show where Amina A. Ford may publish in the future.

Co-authorship network of co-authors of Amina A. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Amina A. Ford. A scholar is included among the top collaborators of Amina A. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amina A. Ford. Amina A. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Radicioni, Giorgia, Agathe Ceppe, Amina A. Ford, et al.. (2021). Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. The Lancet Respiratory Medicine. 9(11). 1241–1254. 108 indexed citations
2.
Radicioni, Giorgia, Roshi Afshar, Morris Ling, et al.. (2020). Allergic asthma is distinguished by sensitivity of allergen-specific CD4+ T cells and airway structural cells to type 2 inflammation. UNC Libraries. 3 indexed citations
3.
Reidel, Boris, Giorgia Radicioni, Phillip W. Clapp, et al.. (2017). E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion. American Journal of Respiratory and Critical Care Medicine. 197(4). 492–501. 252 indexed citations
4.
Abdullah, Lubna H., Jessica Evans, Amina A. Ford, et al.. (2017). Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways. JCI Insight. 2(6). e89752–e89752. 32 indexed citations
5.
Ling, Morris, David C. Adams, Lucas Faustino, et al.. (2016). Allergic asthma is distinguished by sensitivity of allergen-specific CD4 + T cells and airway structural cells to type 2 inflammation. Science Translational Medicine. 8(359). 359ra132–359ra132. 46 indexed citations
6.
Radicioni, Giorgia, Rui Cao, Jerome Carpenter, et al.. (2016). The innate immune properties of airway mucosal surfaces are regulated by dynamic interactions between mucins and interacting proteins: the mucin interactome. Mucosal Immunology. 9(6). 1442–1454. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026